|
|
|
15.01.25 - 07:33
|
Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina (Business Wire)
|
|
|
PARIS--(BUSINESS WIRE)--Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has secured a public tender for the Azienda Ospedaliera Universitaria "Gaetano Martino" in Messina, Italy.
The contract, valued at €668 thousand over three years, includes an option to extend it for two additional years, bringing the total potential value to €1.025 million. The tender covers the supply of alcohol for medical and hospital use, a vital component for maintaining high standards of healthcare services.
Hospitex is accredited as a fiscal warehouse for alcohol by the Italian Customs Agency, a distinction that is among the most challenging to obtain due to complex regulatory, logistical, infrastructural, and administrative requirements. This accreditation demonstrates Hospitex's operational excellence and positions the company as a trusted supplier capable of operating in...
|
|
|
10.01.25 - 08:15
|
Ikonisys finalized a capital increase through the offsetting of debt (Business Wire)
|
|
|
PARIS--(BUSINESS WIRE)--Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories (the “Issuer”), today announces a capital increase of 300k€ through the offsetting of debt owed to Cambria KOP BV, a Dutch investment company, and the emission of 196,080 shares of the Company.
This operation strengthens the Company's net financial position and broadens its shareholder base, reflecting confidence in Ikonisys' future growth. Furthermore, it underscores the appreciation for the significant progress achieved over the past year in consolidating the new ALIKO Scientific group and advancing its mission in innovative cancer diagnostics.
Legal terms of the Capital Increase
The implementation of this capital increase, carried out with cancellation of shareholders' subscription rights through a private placement, was approved by the Board of Directors of the Iss...
|
|
|
31.12.24 - 18:03
|
Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific (Business Wire)
|
|
|
PARIS--(BUSINESS WIRE)--Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories (the “Issuer”), today announces that it has completed the acquisition of Hospitex International Srl, with the issuance of 2 million new Ikonisys shares to ETH Scientific Srl, the former owner of Hospitex.
As disclosed in November 2023, Ikonisys signed an agreement to buy 100% of Hospitex International Srl for a total consideration of €4.5 million, paid through the issuance of 2 million new Ikonisys shares at a price of €2.25 per share. As presented in the half year results, the acquisition of Hospitex was finalized in April 2024. This issuance of shares to the former owner of Hospitex is the last formal step.
It is reminded that, if certain revenue targets are reached by Hospitex by December 31, 2024, an additional €1.125 million will be paid by Ikonisys in June 2025 ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
